Chronic Obstructive Pulmonary Disease in Older Patients

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-60761-727-3_4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• WITHDRAWN: Antibiotics for exacerbations of chronic obstructive pulmonary disease.

  2011cited by this paper
• Cardiovascular Morbidity in COPD: A Study of the General Population

  2011cited by this paper
• Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.

  2011cited by this paper
• Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study

  2010cited by this paper
• Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles

  2010cited by this paper
• Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence

  2010cited by this paper
• Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease.

  2010cited by this paper
• Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study

  2010cited by this paper
• Inhaled corticosteroids and the risks of diabetes onset and progression.

  2010cited by this paper
• Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

  2010cited by this paper
• Clinical practice. Outpatient management of severe COPD.

  2010cited by this paper
• COPD and the risk of depression.

  2010cited by this paper
• Dynamic hyperinflation during daily activities: does COPD global initiative for chronic obstructive lung disease stage matter?

  2010cited by this paper
• A randomized study of endobronchial valves for advanced emphysema.

  2010cited by this paper
• Cardiovascular safety of tiotropium in patients with COPD.

  2010cited by this paper
• Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD

  2010cited by this paper
• Abnormal swallowing reflex and COPD exacerbations.

  2010cited by this paper
• Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.

  2010cited by this paper
• Smoking-related Small Airway Disease—A Review and Update

  2010cited by this paper
• Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

  2010cited by this paper
• Plasma Inflammatory Mediators Associated with Bone Metabolism in COPD

  2010cited by this paper
• Chronic Obstructive Pulmonary Disease Diagnosis and Management in Older Adults

  2010cited by this paper
• Cardiovascular events associated with ipratropium bromide in COPD.

  2010cited by this paper
• Factors affecting the relationship between psychological status and quality of life in COPD patients

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• Cognitive function in COPD

  2010cited by this paper
• Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

  2010cited by this paper
• Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update

  2010cited by this paper
• Increased relative mortality in women with severe oxygen-dependent COPD.

  2010cited by this paper
• Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study.

  2009cited by this paper
• Rehospitalizations among patients in the Medicare fee-for-service program.

  2009cited by this paper
• Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis

  2009cited by this paper
• Falls in patients with chronic obstructive pulmonary disease: a call for further research.

  2009cited by this paper
• Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

  2009cited by this paper
• Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results.

  2009cited by this paper
• Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component.

  2009cited by this paper
• Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.

  2009cited by this paper
• Current status of research on osteoporosis in COPD: a systematic review

  2009cited by this paper
• The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.

  2009cited by this paper
• Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data.

  2009cited by this paper
• Screening for Depression in Chronic Obstructive Pulmonary Disease

  2009cited by this paper
• Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

  2009cited by this paper
• Immunologic aspects of chronic obstructive pulmonary disease.

  2009cited by this paper
• The risk for depression comorbidity in patients with COPD.

  2009cited by this paper
• Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease.

  2009cited by this paper
• The coordination of breathing and swallowing in chronic obstructive pulmonary disease.

  2009cited by this paper
• Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

  2009cited by this paper
• Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

  2009cited by this paper
• Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.

  2009cited by this paper
• Depressive symptoms as predictors of mortality in patients with COPD.

  2009cited by this paper
• ACP Journal Club. Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications.

  2009cited by this paper
• Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

  2009cited by this paper
• A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation.

  2009cited by this paper
• Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease.

  2008cited by this paper
• Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD

  2008cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

  2008cited by this paper
• Palliative and end-of-life care for patients with severe COPD

  2008cited by this paper
• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

  2008cited by this paper
• Physical Activity of Patients With Chronic Obstructive Pulmonary Disease: IMPLICATIONS FOR PULMONARY REHABILITATION

  2008cited by this paper
• The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.

  2008cited by this paper
• Predictors of 6‐Month Mortality in Elderly Patients with Mild Chronic Obstructive Pulmonary Disease Discharged from a Medical Ward After Acute Nonacidotic Exacerbation

  2008cited by this paper
• Age does not hamper the response to pulmonary rehabilitation of COPD patients.

  2008cited by this paper
• Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD.

  2008cited by this paper
• Effects of Home-Based Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease

  2008cited by this paper
• Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment

  2008cited by this paper
• Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2008cited by this paper
• Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.

  2007cited by this paper
• Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

  2007cited by this paper
• Mechanisms of dyspnea in chronic lung disease

  2007cited by this paper
• Clinical application of airway bypass with paclitaxel-eluting stents: early results.

  2007cited by this paper
• Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

  2007cited by this paper
• Intravascular air and CT

  2007cited by this paper
• Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

  2007cited by this paper
• Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.

  2007cited by this paper
• Noninvasive positive pressure ventilation in critical and palliative care settings: Understanding the goals of therapy*

  2007cited by this paper
• Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature

  2006cited by this paper
• Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.

  2006cited by this paper
• Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.

  2006cited by this paper
• Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients.

  2006cited by this paper
• Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.

  2006cited by this paper
• Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients.

  2006cited by this paper
• Global burden of COPD: systematic review and meta-analysis

  2006cited by this paper
• Influenza vaccine for patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• BMC Pulmonary Medicine BioMed Central Study protocol

  2006cited by this paper
• Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial.

  2006cited by this paper
• Non-invasive ventilation for respiratory failure due to acute exacerbations of chronic obstructive pulmonary disease in older patients.

  2006cited by this paper
• COPD: the dangerous underestimate of 15%.

  2006cited by this paper
• Acute exacerbations

  2006cited by this paper
• Antibody response to influenza vaccination in the elderly: a quantitative review.

  2006cited by this paper
• N-Acetylcysteine and Exacerbations of Chronic Obstructive Pulmonary Disease

  2006cited by this paper
• Effect of aging on respiratory system physiology and immunology

  2006cited by this paper
• Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.

  2005cited by this paper
• Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

  2005cited by this paper
• Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study

  2005cited by this paper

• Management of Stable Chronic Obstructive Pulmonary Disease

  2017cites this paper
• Predictors of Exercise Tolerance, Severity of Dyspnea and Quality of Life in Pulmonary Rehabilitation Patients

  2013cites this paper